Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Sebastiano Torrisi"'
Autor:
Theodoros Karampitsakos, Sebastiano Torrisi, Katerina Antoniou, Effrosyni Manali, Ioanna Korbila, Ourania Papaioannou, Fotios Sampsonas, Matthaios Katsaras, Eirini Vasarmidi, Despoina Papakosta, Kalliopi Domvri, Eva Fouka, Ioannis Organtzis, Zoe Daniil, Ilias Dimeas, Paraskevi Kirgou, Konstantinos I. Gourgoulianis, Ilias C. Papanikolaou, Katerina Markopoulou, Georgia Kounti, Eirini Tsapakidou, Efthymia Papadopoulou, Konstantinos Tatsis, Athena Gogali, Konstantinos Kostikas, Vasilios Tzilas, Serafeim Chrysikos, Spyridon Papiris, Demosthenes Bouros, Michael Kreuter, Argyrios Tzouvelekis
Publikováno v:
Respiratory Research, Vol 22, Iss 1, Pp 1-10 (2021)
Abstract Background Idiopathic Pulmonary Fibrosis (IPF) represents a chronic lung disease with unpredictable course. Methods We aimed to investigate prognostic performance of complete blood count parameters in IPF. Treatment-naïve patients with IPF
Externí odkaz:
https://doaj.org/article/58797cb815d347e8ac59a2f2cb5280c4
Publikováno v:
Bio-Protocol, Vol 10, Iss 13 (2020)
Working memory abnormalities involving the prefrontal cortex (PFC) dramatically contribute to poor functional outcomes in patients with schizophrenia and still represent an unmet therapeutic need. Studies in rodents might provide essential tools to u
Externí odkaz:
https://doaj.org/article/93c59ad642d74085b93c4e1ec65131f5
Autor:
Charlotte Hyldgaard, Sebastiano Torrisi, Sissel Kronborg Brix‐White, Thomas Skovhus Prior, Claudia Ganter, Elisabeth Bendstrup, Michael Kreuter
Publikováno v:
Hyldgaard, C, Torrisi, S, Kronborg Brix-White, S, Prior, T S, Ganter, C, Bendstrup, E & Kreuter, M 2023, ' Immunomodulatory treatment in unclassifiable interstitial lung disease : A retrospective study of treatment response ', Respirology, vol. 28, no. 4, pp. 373-379 . https://doi.org/10.1111/resp.14409
Background and Objective: The optimal management of unclassifiable Interstitial lung disease (ILD) remains a challenge. The aim of this study was to describe pulmonary function trajectories for patients treated with immunomodulatory therapy and for u
Autor:
Kalluri, M., Luppi, F., Vancheri, A., Vancheri, C., Balestro, E., Varone, F., Mogulkoc, N., Cacopardo, G., Bargagli, E., Renzoni, E., Torrisi, S., Calvello, M., Libra, A., Pavone, M., Bonella, F., Cottin, V., Valenzuela, C., Wijsenbeek, M., Bendstrup, E., 3rd International Summit for ILD (ISILD), Erice collaborators listed below: Carlo Albera, Goksel, Altinisik, Kjetil, Ask, Elisabetta, Balestro, Elena, Bargagli, Elisabeth, Bendstrup, Marialuisa, Bocchino, Francesco, Bonella, Martina, Bonifazi, Giulia, Cacopardo, Maria, Calvello, Diego, M Castillo, Nazia, Chaudhuri, Ulrich, Costabel, Vincent, Cottin, Bruno, Crestani, Manuela, Funke-Chambour, Jack, Gauldie, Peter, M George, Johannes, C Grutters, Sergio, Harari, Richard, G Jenkins, Kerri, A Johannson, Mark, G Jones, Meena, Kalluri, Michael, P Keane, Maria, A Kokosi, Michael, Kreuter, Donato, Lacedonia, Brett, Ley, Alessandro, Libra, Fabrizio, Luppi, Toby, M Maher, George, A Margaritopoulos, Fernando, J Martinez, Jelle, Miedema, Nesrin, Mogulkoc, Maria, Molina-Molina, Philip, L Molyneaux, Julie, Morisset, Stefano, Palmucci, Mauro, Pavone, Ganesh, R Raghu, Elisabetta, A Renzoni, Luca, Richeldi, Gianluca, Sambataro, Alfredo, Sebastiani, Paolo, Spagnolo, Giulia Maria Stella, Martina, Sterclova, Irina, Strambu, Tomassetti, Sara, Sebastiano, Torrisi, Jacopo, Simonetti, Haluk, Turktas, Argyrios, Tzouvelekis, Claudia, Valenzuela, Ada, Vancheri, Carlo, Vancheri, Francesco, Varone, Patrizio, Vitulo, Athol, U Wells, Marlies, S Wijsenbeek, Wim, A Wuyts
Publikováno v:
Kalluri, M, Luppi, F, Vancheri, A, Vancheri, C, Balestro, E, Varone, F, Mogulkoc, N, Cacopardo, G, Bargagli, E, Renzoni, E, Torrisi, S, Calvello, M, Libra, A, Pavone, M, Bonella, F, Cottin, V, Valenzuela, C, Wijsenbeek, M & Bendstrup, E 2021, ' Patient-reported outcomes and patient-reported outcome measures in interstitial lung disease : Where to go from here? ', European Respiratory Review, vol. 30, no. 160, 210026 . https://doi.org/10.1183/16000617.0026-2021
Patient-reported outcome measures (PROMs), tools to assess patient self-report of health status, are now increasingly used in research, care and policymaking. While there are two well-developed disease-specific PROMs for interstitial lung diseases (I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d275fa6f4c9d288e057b19ec86ed6b07
http://hdl.handle.net/10044/1/101501
http://hdl.handle.net/10044/1/101501